A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder (Q84446951)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

obsessive-compulsive disorder

6 February 2020

main subject

0 references

1 reference

1 reference

J Bisserbe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

R Lane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

M Flament

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Franco-Belgian OCD Study Group

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

82-93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Increasing frequency of the diagnosis of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Sertraline 50 mg daily: the optimal dose in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Weight gain. A side-effect of tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Sertraline in the prevention of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Obsessive compulsive disorder in adolescence: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine and exposure for obsessive-compulsive rituals: i

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2897%2989646-0

7 January 2021

10.1016/S0924-9338(97)89646-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698511%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference